Slow-binding inhibition of 2-keto-3-deoxy-6-phosphogluconate (KDPG) aldolase

Autor: Casimir Blonski, Laurence Hecquet, Rémi Braga
Přispěvatelé: Synthèse et étude de systèmes à intêret biologique (SEESIB), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)
Rok vydání: 2004
Předmět:
Zdroj: Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, Elsevier, 2004, 12, pp.2965-2972. ⟨10.1016/j.bmc.2004.03.039⟩
Bioorganic and Medicinal Chemistry, 2004, 12, pp.2965-2972. ⟨10.1016/j.bmc.2004.03.039⟩
ISSN: 0968-0896
1464-3391
DOI: 10.1016/j.bmc.2004.03.039
Popis: 2-Keto-3-deoxy-6-phosphogluconate (KDPG) aldolase is a key enzyme in the Entner–Doudoroff pathway of bacteria. It catalyzes the reversible production of KDPG from pyruvate and d -glyceraldehyde 3-phosphate through a class I Schiff base mechanism. On the basis of aldolase mechanistic pathway, various pyruvate analogues bearing β-diketo structures were designed and synthesized as potential inhibitors. Their capacity to inhibit aldolase catalyzed reaction by forming stabilized iminium ion or conjugated enamine were investigated by enzymatic kinetics and UV–vis difference spectroscopy. Depending of the substituent R (methyl or aromatic ring), a competitive or a slow-binding inhibition takes place. These results were examined on the basis of the three-dimensional structure of the enzyme.
Databáze: OpenAIRE